Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study

<p dir="ltr">Anemia is a global health problem, and the most common cause is iron deficiency anemia (IDA). Although blood transfusion is considered for patients with hemoglobin (Hb) values below 7 g/dl, the optimal transfusion threshold for slowly developing anemia in ambulatory pati...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Obaidullah Zafar (17910572) (author)
مؤلفون آخرون: Suha Turkmen (50126) (author), Haris Iftikhar (15954223) (author), Jassim Mohammad (21165296) (author), Tarek Alrefi (21165299) (author), Alamgir Qureshi (21165302) (author), Adel Alhariri (21165305) (author), Ebtesam Eltayeb (21165308) (author), Serdar Karakulukcu (21165311) (author), Mariam Almalaheem (21165314) (author)
منشور في: 2025
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513550025752576
author Obaidullah Zafar (17910572)
author2 Suha Turkmen (50126)
Haris Iftikhar (15954223)
Jassim Mohammad (21165296)
Tarek Alrefi (21165299)
Alamgir Qureshi (21165302)
Adel Alhariri (21165305)
Ebtesam Eltayeb (21165308)
Serdar Karakulukcu (21165311)
Mariam Almalaheem (21165314)
author2_role author
author
author
author
author
author
author
author
author
author_facet Obaidullah Zafar (17910572)
Suha Turkmen (50126)
Haris Iftikhar (15954223)
Jassim Mohammad (21165296)
Tarek Alrefi (21165299)
Alamgir Qureshi (21165302)
Adel Alhariri (21165305)
Ebtesam Eltayeb (21165308)
Serdar Karakulukcu (21165311)
Mariam Almalaheem (21165314)
author_role author
dc.creator.none.fl_str_mv Obaidullah Zafar (17910572)
Suha Turkmen (50126)
Haris Iftikhar (15954223)
Jassim Mohammad (21165296)
Tarek Alrefi (21165299)
Alamgir Qureshi (21165302)
Adel Alhariri (21165305)
Ebtesam Eltayeb (21165308)
Serdar Karakulukcu (21165311)
Mariam Almalaheem (21165314)
dc.date.none.fl_str_mv 2025-04-14T09:00:00Z
dc.identifier.none.fl_str_mv 10.1007/s42399-025-01840-4
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Effectiveness_of_Intravenous_Iron_Therapy_in_the_Management_of_Severe_Iron_Deficiency_Anemia_A_Retrospective_Study/28846523
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Medical biochemistry and metabolomics
Health sciences
Public health
Anemia
Iron deficiency
Blood transfusion
Intravenous iron therapy
dc.title.none.fl_str_mv Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Anemia is a global health problem, and the most common cause is iron deficiency anemia (IDA). Although blood transfusion is considered for patients with hemoglobin (Hb) values below 7 g/dl, the optimal transfusion threshold for slowly developing anemia in ambulatory patients has not been clearly defined. IDA can progress slowly, allowing the hemodynamic system to compensate and prevent symptoms, even at very low hemoglobin levels, particularly in young, healthy individuals. Transfusion decisions should be individualized to the severity of symptoms rather than simply hemoglobin levels. The aim of this study is to retrospectively evaluate outpatients with iron deficiency anemia who refused blood transfusion and were treated with intravenous iron supplementation. This study is a retrospective study based on medical records. The patients with Hb level below 7 were found from medical records. The patients who did not undergo blood transfusion and were treated with IV iron were identified. The response to parenteral iron replacement therapy in severe IDA was evaluated in terms of improvement in hemoglobin, hematocrit, and ferritin levels and whether any complications developed. The study included 84 patients, with 89.3% being women and 10.7% men, and an average age of 35.1 years. The most common symptoms reported were fatigue, dizziness, and pallor. Hemoglobin levels significantly increased from 6.4 to 11.1 g/dl (<i>p</i> < 0.001) after IV iron treatment, as did ferritin levels, while total iron-binding capacity decreased. No complications, mortality, or morbidity were reported. Anemia such as IDA may develop without serious symptoms, even if Hb levels are below 7. It is important to manage these individuals with personalized care rather than relying solely on Hb levels for blood transfusion decisions. IV iron therapy can effectively raise Hb levels and reduce associated risks by reducing unnecessary blood transfusions. These findings highlight the need for individualized IV iron therapy as a first-line treatment in young healthy patients to improve outcomes and optimize healthcare resources.</p><h2>Other Information</h2><p dir="ltr">Published in: SN Comprehensive Clinical Medicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s42399-025-01840-4" target="_blank">https://dx.doi.org/10.1007/s42399-025-01840-4</a></p>
eu_rights_str_mv openAccess
id Manara2_9d319177e3f2bf1363d8a3e3800ccbea
identifier_str_mv 10.1007/s42399-025-01840-4
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/28846523
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective StudyObaidullah Zafar (17910572)Suha Turkmen (50126)Haris Iftikhar (15954223)Jassim Mohammad (21165296)Tarek Alrefi (21165299)Alamgir Qureshi (21165302)Adel Alhariri (21165305)Ebtesam Eltayeb (21165308)Serdar Karakulukcu (21165311)Mariam Almalaheem (21165314)Biomedical and clinical sciencesCardiovascular medicine and haematologyClinical sciencesMedical biochemistry and metabolomicsHealth sciencesPublic healthAnemiaIron deficiencyBlood transfusionIntravenous iron therapy<p dir="ltr">Anemia is a global health problem, and the most common cause is iron deficiency anemia (IDA). Although blood transfusion is considered for patients with hemoglobin (Hb) values below 7 g/dl, the optimal transfusion threshold for slowly developing anemia in ambulatory patients has not been clearly defined. IDA can progress slowly, allowing the hemodynamic system to compensate and prevent symptoms, even at very low hemoglobin levels, particularly in young, healthy individuals. Transfusion decisions should be individualized to the severity of symptoms rather than simply hemoglobin levels. The aim of this study is to retrospectively evaluate outpatients with iron deficiency anemia who refused blood transfusion and were treated with intravenous iron supplementation. This study is a retrospective study based on medical records. The patients with Hb level below 7 were found from medical records. The patients who did not undergo blood transfusion and were treated with IV iron were identified. The response to parenteral iron replacement therapy in severe IDA was evaluated in terms of improvement in hemoglobin, hematocrit, and ferritin levels and whether any complications developed. The study included 84 patients, with 89.3% being women and 10.7% men, and an average age of 35.1 years. The most common symptoms reported were fatigue, dizziness, and pallor. Hemoglobin levels significantly increased from 6.4 to 11.1 g/dl (<i>p</i> < 0.001) after IV iron treatment, as did ferritin levels, while total iron-binding capacity decreased. No complications, mortality, or morbidity were reported. Anemia such as IDA may develop without serious symptoms, even if Hb levels are below 7. It is important to manage these individuals with personalized care rather than relying solely on Hb levels for blood transfusion decisions. IV iron therapy can effectively raise Hb levels and reduce associated risks by reducing unnecessary blood transfusions. These findings highlight the need for individualized IV iron therapy as a first-line treatment in young healthy patients to improve outcomes and optimize healthcare resources.</p><h2>Other Information</h2><p dir="ltr">Published in: SN Comprehensive Clinical Medicine<br>License: <a href="https://creativecommons.org/licenses/by/4.0" target="_blank">https://creativecommons.org/licenses/by/4.0</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1007/s42399-025-01840-4" target="_blank">https://dx.doi.org/10.1007/s42399-025-01840-4</a></p>2025-04-14T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1007/s42399-025-01840-4https://figshare.com/articles/journal_contribution/Effectiveness_of_Intravenous_Iron_Therapy_in_the_Management_of_Severe_Iron_Deficiency_Anemia_A_Retrospective_Study/28846523CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/288465232025-04-14T09:00:00Z
spellingShingle Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
Obaidullah Zafar (17910572)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Medical biochemistry and metabolomics
Health sciences
Public health
Anemia
Iron deficiency
Blood transfusion
Intravenous iron therapy
status_str publishedVersion
title Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
title_full Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
title_fullStr Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
title_full_unstemmed Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
title_short Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
title_sort Effectiveness of Intravenous Iron Therapy in the Management of Severe Iron Deficiency Anemia: A Retrospective Study
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Clinical sciences
Medical biochemistry and metabolomics
Health sciences
Public health
Anemia
Iron deficiency
Blood transfusion
Intravenous iron therapy